key: cord-0307647-j5gnvhsg
authors: Pang, Yui Tik; Acharya, Atanu; Lynch, Diane L.; Pavlova, Anna; Gumbart, James C.
title: SARS-CoV-2 spike opening dynamics and energetics reveal the individual roles of glycans and their collective impact
date: 2021-08-13
journal: bioRxiv
DOI: 10.1101/2021.08.12.456168
sha: 0a62e2b343ebab95766998f97459bceb2e9e83ee
doc_id: 307647
cord_uid: j5gnvhsg

The trimeric spike (S) glycoprotein, which protrudes from the SARS-CoV-2 viral envelope, is responsible for binding to human ACE2 receptors. The binding process is initiated when the receptor binding domain (RBD) of at least one protomer switches from a “down” (closed) to an “up” (open) state. Here, we used molecular dynamics simulations and two-dimensional replica exchange umbrella sampling calculations to investigate the transition between the two S-protein conformations with and without glycosylation. We show that the glycosylated spike has a higher barrier to opening than the non-glycosylated one with comparable populations of the down and up states. In contrast, we observed that the up conformation is favored without glycans. Analysis of the S-protein opening pathway reveals that glycans at N165 and N122 interfere with hydrogen bonds between the RBD and the N-terminal domain in the up state. We also identify roles for glycans at N165 and N343 in stabilizing the down and up states. Finally we estimate how epitope exposure for several known antibodies changes along the opening path. We find that the epitope of the BD-368-2 antibody remains exposed irrespective of the S-protein conformation, explaining the high efficacy of this antibody. Graphical TOC Entry

The ongoing COVID-19 pandemic caused by the SARS-CoV-2 coronavirus quickly spread worldwide with unprecedented detrimental impact on global health and economies. 1 Although deployment is ongoing and not uniform worldwide, the rapid development of several vaccines 2 as well as monoclonal antibody treatments 3 have produced the first successful phase in mitigating the current viral outbreak. However, the emerging threat of variants 4, 5 and the possibility of future coronavirus outbreaks 6 necessitate a thorough understanding of the viral life cycle, including recognition, binding, and infection. SARS-CoV-2 infection is initiated by the recognition of, and binding to, the host-cell angiotensin-converting enzyme 2 (ACE2) receptor. 7, 8 This process is mediated by the SARS-CoV-2 spike (S) protein, a homotrimeric class I fusion glycoprotein that protrudes from the surface of the SARS-CoV-2 virion. Release of the S-protein sequence in early 2020, combined with earlier structural work on related betacoronaviruses, has led to the rapid determination of structures of solublized, pre-fusion stablized S-protein ectodomain constructs [9] [10] [11] [12] [13] [14] (Fig. 1) .

Each protomer consists of the S1 and S2 subunits separated by a multibasic furin cleavage site. S1 contains the receptor binding domain (RBD) and mediates host cell recognition while S2 consists of the membrane fusion machinery necessary for viral entry. 7 The S-protein is a major antigenic target with multiple epitopes that are targeted by the human immune system, including the RBD and the N-terminal domain (NTD). 5, [15] [16] [17] Moreover, glycosylation of the S-protein aids in masking and shielding the virus from host immune system response. [18] [19] [20] The S-protein is characterized by down and up conformational states, which transiently interconvert via a hinge-like motion exposing the receptor binding motif (RBM), which is composed of RBD residues S438 to Q506. 21 The RBM is buried in the inter-protomer interface of the down S-protein; therefore, binding to ACE2 relies on the stochastic interconversion between the down and up states.

Cryo-electron microscopy (cryo-EM) studies have revealed detailed structural information for both the up and down conformational states. 22 However, relatively few studies have up states, as well as for inter-residue interactions and details of binding to ACE2. 19, 20, [24] [25] [26] Opening pathways determined using steered MD and targeted MD have been reported. [26] [27] [28] More recently, extensive simulations using enhanced sampling techniques such as weighted ensemble 29 and fluctuation amplification of specific traits (FAST) adaptive sampling combined with Folding@home 30 have provided details of multiple pathways for the S-protein opening. Moreover, features of the energy landscape of these conformational transitions that are necessary for viral binding and entry are beginning to emerge. 27, 28, 31 A recent study by Amaro and coworkers has highlighted the functional role of glycans at N165 and N234 beyond shielding 24 based on separate equilibrium simulations of the Sprotein down and up states. When the RBD transitions to the up state, the glycan at N234 rotates into the resulting void, stablizing the up conformation. Moreover, MD simulations and mutagenesis have revealed contributions of the glycan at N343 to the dynamics of RBD opening and ACE2 binding. 29 These results suggested a role for the glycan at N343 in the opening conformational transition via "lifting" the RBD through sequential interactions with multiple RBD residues, referred to as "glycan gating".

Here, we describe newly determined two-dimensional (2D) free-energy landscapes of the SARS-CoV-2 S-protein opening and closing transitions using replica exchange umbrella sampling (REUS) simulations for glycosylated as well as un-glycosylated S-protein. We highlight the impact of glycans on each state and on the kinetics of spike opening. Furthermore, we analyzed the exposure of prominent epitopes on the S-protein surface and provide a dynamic picture of antibody binding along the spike-opening path. Finally we report the results of equilibrium MD simulations of the glycosylated and un-glycosylated systems for the down as well as up conformational states in order to further characterize the stabilizing role of the glycans.

Using REUS simulations, we studied the free-energy change from the down state of spike to the up state when fully glycoslyated as well as when un-glycosylated. We modeled the wild-type (WT) up state based on the diproline mutant structure from Walls et al. 10 (PDB: 6VYB). The down-state was modeled using a more recent structure from Cai et al. 11 (PDB: 6XR8) without the diproline mutations. The glycan with highest population in the mass spectroscopy data from Crispin and coworkers 18 at each site was added using the GLYCAM Web server developed by the Woods group (http://glycam.org). 32, 33 Additional details of the system are provided in Methods.

We first ran metadynamics simulations of the cryo-EM structures in the down and up states, allowing them to explore the conformational space between them. This space is (Fig. 1c,d) . The down and up states from the cryo-EM structures are located in the lower-left and upper-right regions, respectively. The black line shows the MEP for each system. (c) The free energies along the MEPs of both structures were extracted and plotted against the path parameter λ, which goes from 0 (down-state energy minimum) to 1 (up-state energy minimum). For the glycosylated system, the conformations from the two cryo-EM structures emerged as energy minima on the 2D potential of mean force (PMF) as expected (Fig. 2a ). The energy difference between the two minima is small, with the up state possessing a slightly higher energy than the down state by 0.4 kcal/mol (Fig. 2c) . A recent study from Simmerling and coworkers also found the down state to be of a lower energy than the up state using US with a different set of collective variables. 31 It is worth noting that the up-state energy minimum is located at the corner of the conformational space explored, and the true minimum may be beyond the explored region. This suggests that the true energy-minimum up state may be more "open" than the cryo-EM structure, as also found by other computational studies. 29, 30 To compensate for the missing fractions of the energy wells, we fitted Gaussian distributions to the population distribution represented by those regions of the PMF ( Fig. S4 ; see the Supporting Information). With this expansion, we determined that the down and up state populations are 54% and 46%, respectively, consistent with the population distribution determined from cryo-EM structure classification. 10, 13 We also computed the minimum energy path (MEP) 34, 35 connecting the down and up states (Fig. 2a,c) . The path is mostly diagonal on the 2D PMF, with the exceptions of a sharp increase of ϕ while exiting the down-state energy well and a slight decrease of ϕ when entering the up-state energy well. The energy barrier separating the two stable conformations has a height of 7.4 kcal/mol and is located at d = 54.9 Å.

The PMF for the un-glycosylated system is significantly different from the glycosylated one ( Fig. 2b) . Without the glycans, the up state has a lower free energy than the down state by 2.2 kcal/mol. Notably, the energy minimum of the up state shifts towards the down state when glycans are excluded, with the center of the energy well moving from (d, ϕ) = (72.5, -0.1) to (68.2, -2.6). The energy barrier between the two states is also shifted to d = 51.9 Å, with its height lowered to 2.5 kcal/mol when measured from the down state.

With a deeper and wider energy well for the up state, the equilibrium population shifts from a balanced distribution between two states to one that substantially favors the up state.

Comparing the volume of the fitted Gaussian distributions, 95% of the population will be in the up state and only 5% will be in the down state. This is in apparent contrast with other studies in which removing some glycans around the RBD individually (N234, N165, and N343) decreased ACE2 binding, suggesting that the down state becomes more favored. 24, 29 However, this may be altered further when all glycans are removed, as done here.

To quantify the kinetics of S-protein opening, we first computed the mean first passage time (MFPT) along the MEP using the Smoluchowski diffusion equation for the glycosylated system. 36, 37 Additional constrained simulations were run to determine the diffusion coefficient along the MEP using the velocity autocorrelation function (VACF). 38, 39 The MFPT from the down state to the up state is 10.1 ms, while the reverse is 2.5 ms. Comparing with experimental observation by single-molecule FRET, 23 it appears that the MFPTs here are underestimated, possibly due to the fact that we did not account for the long timescale for glycans to equilibrate when computing the diffusion coefficient. For example, the glycan at N234 has to escape from the cavity under the RBD in the up-to-down transition. 24 We also approximated the MFPT for the un-glycosylated system. The reduced transition barrier in the PMF (Fig. 2c ) led to a concomitant reduction in the MFPT, which is 5 µs for the down-to-up transition and 305 µs for the up-to-down transition.

Next, we considered the chemical dynamics according to the following paired reactions:

in which D represents the down state of the S-protein, U the up state, and U:ACE2 the bound state (Fig. 3) . The open/close rates (k open /k close ) are determined by the MFPTs and the binding/unbinding rates (k on /k off ) for S-protein to ACE2 are taken from Wrapp et al. 9 After solving the Master equation for these reactions ([ACE2] i = 50 nM), we find that for the glycosylated S-protein at equilibrium, the fraction of bound states is 40%, of up-but-unbound states is 12%, and of down states is 48%. For the un-glycosylated S-protein, the populations shift to 77% bound, 23% up-but-unbound, and 0% down (Fig. 3b-f ). However, removing glycans not only affects the up/down population, it also may affect the binding/unbinding rates k on and k off . Deep mutational scanning of the RBD found any mutation to N343, which eliminates the glycan bound at this position, is detrimental, with an inferred ∆∆G of +0.35 to 2.03 kcal/mol. 40 Using our approximate open/close rates for the un-glycosylated S-protein but modifying the binding/unbinding rates according to the mutation data, we find that the bound-state population decreases to between 10% (∆∆G = 2.03 kcal/mol) and 65% (∆∆G = 0.35 kcal/mol). Thus, even though removing all glycans increases the population of the up state significantly in our calculations, an associated reduction in binding affinity could eliminate the otherwise expected gain in the ACE2-bound-state population. 

To better characterize the effects of glycans on the energetics of spike opening, we examined how the RBD interacts with the rest of the protein when glycans are present or absent in the REUS simulations. We calculated the number of hydrogen bonds between the opening RBD-A and the rest of the protein. We found that this number decreases generally as RBD-A opens up, with a slight but distinct increase in interactions after crossing the energy barrier ( Fig. 4a,b) , both with and without glycans. The general trend is explained by the fact that RBD-A moves away from the rest of the protein when it is fully open and consequently breaks contact with the rest of the trimeric S-protein, including neighboring RBDs and S2 domains. However, this movement is insufficient on its own to explain the more drastic decrease in the number of hydrogen bonds when glycans are present.

We further analyzed the MEP to answer two non-trivial questions, (1) why the number of hydrogen bonds increases after crossing the barrier during opening and (2) that when the spike opens widely, the glycans at N165 and N122 intercalate between RBD-A and NTD-B, disrupting the hydrogen bonds between them (Fig. 4e ). This observation is further supported by contact analysis, which shows that the number of contacts between the glycans at N122 and N165 and the β-sheets of NTD-B and RBD-A increases steadily as RBD-A approaches the up state (Fig. S5) . Therefore, the up state is more stable, and hence more populated, without glycans as seen in the PMFs.

We also applied the hydrogen bond analysis to elucidate the difference between the free energy landscapes from the REUS simulations with and without glycans. We plotted the average number of hydrogen bonds between the opening RBD-A and its neighboring NTD-B as a function of the two collective variables, d and ϕ, which shows that the increase in interactions between RBD-A and NTD-B is not limited to states along the MEP but also includes a large region on the +d-side of the energy barrier (Fig. 4c) . As RBD-A moves away from NTD-B, it also gets closer to neighboring RBD-C, forming hydrogen bonds with it when ϕ is large (Fig. 4d) . The shift from RBD-A forming hydrogen bonds with RBD-C to forming them with NTD-B can, at least in part, provide an explanation for the ∼8 kcal/mol energy barrier as well as the bump in 

In order to assess the long-timescale dynamics of the glycans, we performed two 2-µs equilibrium simulations of both the glycosylated and un-glycosylated systems. When projected onto the two collective variables used in REUS, all three protomers in the down state for both replicas remained in the down conformation, both with and without glycans (Fig. S3a) .

However, the up protomer in the up state behaves differently with and without glycans.

Specifically, RBD-A in replica #2 in the presence of glycans transitioned from the initial up conformation towards the down conformation, stopping at the +d-side of the barrier (Fig. S3b, yellow points) , reiterating the higher stability of the up state in the abscence of glycans as determined from the REUS simualtions.

We also analyzed the interactions of glycans around RBD-A, namely those at N165, N234, and N343 of the neighboring chain B, using the equilibrium simulations as well as the REUS trajectories along the MEP. Recently, Amaro and coworkers conducted all-atom MD simulations and mutation experiments to study the individual roles of the above glycans on Our simulations also reveal roles for the glycans at N165 and N343 in stabilizing both the up and down states. Specifically, when RBD-A is in the down state, glycans at N165 and N343 wrap around the RBM (Fig. 5a) , keeping it in the down state. A similar interaction was observed in another study when a glycan at N370 was artificially introduced; it wrapped around the down-state RBD like a "shoelace". 20 Remarkably, the glycan at N165 also stabilizes the up-state RBD by supporting part of the exposed RBM (Fig. 5b) . The inter-glycan contact between glycans at N343 and N165 is significantly higher in the up state compared to the down state (Fig. S10) , suggesting that the glycan at N343 indirectly stabilizes the open state by interacting with the glycan at N165 (Fig. 5b) . The two glycans also prevent the flexible RBM from attaching to the neighboring down-state RBD and becoming inaccessible to ACE2, as observed in one of our equilibrium simulations of the un-glycosylated system (Fig. S2) .

The above observations are confirmed by the contact analysis on the REUS trajectories along the MEP. The glycans at N165 and N343 both interact with the RBM in the down state as illustrated by the average contact values between RBD-A and glycans at N165 and N343 ( Figure S8, S9) . As the spike opens, the glycan at N165 switches to interact with RBD-A residues below the RBM, while the glycan at N343 barely contacts RBD-A after the system crosses the activation barrier of opening (Fig. 5c) retains the WT K986/V987 sequence, rather than the double proline mutations commonly made in the production of stabilized pre-fusion spike proteins; they report a shifting inwards (and, thus, tighter packing) of the S1 subunits when compared to the earlier solubilized ectodomain structures. 11 In fact, the loss of a putative salt bridge between K986 and an aspartic acid (D427/D428) on an adjacent protomer has been implicated in producing the less tightly packed structures seen in the solubilized mutant constructs. 11 In our equilibrium simulations this salt bridge has an ∼30% occupancy, averaged over all three protomers in the two independent trajectories. Reduction in the aforementioned salt bridge occupancy originates from competing with intra-protomer salt bridges between K986 and nearby acidic residues E748, E990, and D985, present in the ∼15-25% range, suggesting transient interaction between K986 and the RBD aspartic acids (D427/D428). These competing interactions are illustrated in Fig. S11 .

We repeated the REUS simulation with the diproline mutation for the un-glycosylated system. The resulting PMF has very similar features as compared to the WT one, with the up state having a higher energy than the down state and an energy barrier near the down state (Fig. S12) . Along with the transient nature of the K986/D427 salt bridge, the similarity of this PMF with WT ( Fig. 2) suggest that while the electrostatic interaction between the S2 subdomain and the RBD of the up protomer may have modulatory effects on S-protein dynamics, the major impact of the proline mutations is likely to be their tendency to break and distort α-helices. The HR1-CH turn region undergoes a large conformational change upon the transition from the pre-to post-fusion states, forming an extended α-helix. 11 The presence of the prolines, residues known to break/kink α-helices, inhibits the formation of the long α-helix characteristic of the post-fusion conformation. 42 In fact, Gobeil et al. 12 report that for the S-protein construct with the furin site removed, the presence of the prolines produces structures, ACE2 binding, thermal stability, and antibody binding that are remarkably similar to the WT K986/V987 pair. Of note, recent simulations by Wang et al. 43 exploring the transition from the pre-to post-fusion states have shown that while the WT sequence at 986/987 has a tendency to become helical, replacement with prolines disrupts the formation of this secondary structure.

In the last year, more than one thousand neutralising antibodies targeting the SARS-CoV-although some target the NTD and other non-RBD epitopes. 46 According to the continuously updated CoV-AbDab database, 47 a total of 1069 (and growing) neutralizing antibodies target the S-protein, while only 132 target non-RBD epitopes. One advantage of targeting non-RBD epitopes on the S-protein is that they can be recognized even when the RBD is in a down conformation. 19, 48 In contrast, the RBD can only be identified in the up conformation owing to the strong glycan coverage of RBD in the down conformation. 24 Figure 6 : Epitope analysis for selected antibodies. (a) Exposed area on antibody epitopes (AbASA) in the presence of protein and glycans. (b) Surface area of epitopes covered by glycans along the MEP quantified by subtracting the two AbASA values calculated with and without glycans. All accessible surface area calculations were performed using a 7 Å probe.

To understand the effect of spike-opening dynamics on epitope exposure, we calculated the accessible surface area of a number of epitopes along the MEP identified from REUS. We selected seven different antibodies 16, 17, [49] [50] [51] [52] [53] with epitopes spanning multiple regions on RBD-A (including cryptic epitopes) and the NTD-B of the S-protein. Details of these antibodies are provided in the Supporting Information. We performed separate antibody accessible surface area (AbASA) calculations including and excluding the glycans using the same sampling approach with a 7-Å probe. A similar probe size 19 as well as a smaller one 30 were used in previous studies. While this moderate (7-Å) probe size may make some crevices appear slightly exposed, 19 it is optimal for cryptic epitopes. 30 In general, the AbASA either remains the same or increases significantly when RBD-A transitions to the up state. The epitope of the STE90-C11 52 antibody has a jump in AbASA during the closed-to-open transition. The CR3022 antibody binds to a cryptic epitope, 50 which is completely covered in the down state and is only slightly exposed in the up state. Remarkably, the AbASA of the 2-4 antibody does not change during the down-to-up transition of the RBD, in spite of the epitope being located in the RBM (Fig.   6a ). Therefore, we conclude that the entire RBM does not become exposed even in the up state. The AbASA for the epitope of the 4A8 antibody does not change significantly during spike opening since its epitope is located in the N-terminus, 17 54 Surprisingly, the epitope of the S309 antibody 51 becomes less exposed in the open state without an increase in coverage by the glycans (Fig. 6b) , indicating that a part of the RBD (Table S2 ) also become less exposed in the up state compared to the down state.

inter-converts between up and down states with only the up state allowing for ACE2 binding.

Consequently, the energetics of the inter-conversion control the initiation of infection. To this end, we computed a two-dimensional energy landscape of the SARS-CoV-2 S-protein updown inter-conversion. Using multiple REUS calculations, we elucidate the collective roles of S-protein glycans in its opening dynamics. Our results indicate that the free-energy barrier of spike opening is ∼2 kcal/mol higher in the presence of glycans compared to the fully unglycosylated spike. While the up and down populations are approximately balanced in the presence of the glycans, the up state of the S-protein becomes almost exclusively populated without glycans. One may assume more up-state S-proteins would present a higher chance of binding ACE2 receptors and hence increase its viral fitness. However, there are a few opposing effects of having more up-state S-proteins as indicated by a prior study 24 and reaffirmed by our analysis. The RBD in the down state is heavily shielded by glycans, 19, 24 while in the up state, it is more exposed to neutralizing antibodies (Fig. 6a) . Furthermore, ACE2 binding strongly depends on the binding affinity between ACE2 and the S-protein, which may involve interactions with glycans as well as protein. Therefore, a high up-state population does not necessarily reflect a high ACE2-bound-state population.

The epitopes of antibodies on the spike can be protected either by protein residues or by glycans, and the coverage provided by each changes in an epitope-dependent manner along the spike opening path. The STE90-C11 antibody has the greatest epitope exposure when the RBD is open, while the BD-368-2 antibody has an epitope that is always significantly exposed, irrespective of the RBD's position. Additionally, the exposure of the BD-368-2 epitope is very similar to the epitope of STE90-C11 in the up state. Therefore, these two antibodies show very high efficiency in neutralizing SARS-CoV-2 S-protein, both with subnanomolar IC 50 values. 49, 52 The CR3022 antibody binds to a cryptic epitope; consequently, its AbASA is smaller compared to other epitopes. However, the lack of exposed surface area, even in the up state, is compensated for by strong electrostatic interactions at the epitope-CR3022 interface. 55 We analyzed interactions of individual glycans with different domains of the S-protein using the two MEPs obtained, one with and one without glycans. The glycans at N122 and N165 disrupt the hydrogen bonds between the opening RBD-A and the neighboring NTD-B, destabilizing the up state and hence pushing the equilibrium population towards the down state when compared to the un-glycosylated system. The glycans at N165 and N343 also stabilize the RBD-A down state by wrapping around the RBM. Conversely, the glycan at N343 serves as the so-called "glycan gate" propping up the RBM, 29 while the glycan at N165 helps by supporting the up-state RBD-A with the aid of the glycan at N343. Consequently, these two glycans stabilize both down and up states, creating a local minimum for each.

The complicated role of the glycan at N165 may explain conflicting experimental results regarding whether the N165A mutation increases or decreases spike binding. 24, 56 In closing, we calculated the energetics along the spike-opening path for SARS-CoV-2 S-protein with atomic-level insight into the roles of glycans in the opening process. Furthermore, we highlighted how changes in energetics impact the kinetics of ACE2 binding and epitope exposure. These findings, especially the conformations along the spike-opening path, will facilitate the design of effective nanobodies and antibodies to fight the ongoing COVID-19 crisis. This latter region is adjacent to a critical lysine (K854) that provides a salt bridge partner for D614. The loss of this salt bridge has been implicated in the increased infectivity of the currently predominant D614G SARS-CoV-2 strains. Furthermore, Cai et al. 11 also resolved two disulfide bonds that were previously missing, one in the N-terminal (C15-C136) and

another in the central helix/loop region (C840-C851). In our model, the missing residues in the down-state structures were added with SWISS model 57 using the 6XR8 structure as a template. The model was cleaved at the furin cleavage site between residues R685 and S686. The S1 part, which contains the RBD and NTD, is more closely packed in the 6XR8 structure compared to the 6VXX, and the S2 part, which contains the HR1 and CH, is aligned between them. 11 The S1 and S2 part of our model include residues N14-R685 and S686-S1147, respectively. Ten disulfide linkages are added in the S1 part between residues C15-C136, C131-C166, C291-C301, C336-C361, C379-C432, C391-C525, C480-C488, C538- 

All simulations were performed using NAMD 2.14 58,59 with the CHARMM36m protein force field, 60 CHARMM36 glycan force field, 61 and TIP3P water. 62 Each system was equilibrated for 5 ns with the temperature and pressure fixed at 310 K and 1 atm, respectively, using Langevin dynamics and piston, 63 respectively. A 2-fs time step was used, with long-range electrostatics calculated every other time step using the particle-mesh Ewald method. 64 A short-range cutoff for Lennard-Jones interactions was set at 12 Å, with a switching function beginning at 10 Å. Bonds involving hydrogen atoms were constrained to their equilibrium length, employing the SETTLE algorithm for water molecules and the SHAKE algorithm for all others.

We also ran metadynamics, simulated annealing and REUS simulations. Additional details are provided in the Supporting Information. Details of modeling steps, glycosylation, collective-variables, definitions of epitopes, additional analysis, and two movies are provided in the SI

Characteristics of SARS-CoV-2 and COVID-19

SARS-CoV-2 Vaccine Development: An Overview and Perspectives

Neutralizing monoclonal antibodies for treatment of COVID-19

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

SARS-CoV-2 variants, spike mutations and immune escape

Bats in ecosystems and their Wide spectrum of viral infectious potential threats: SARS-CoV-2 and other emerging viruses

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Veesler, D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein

Distinct conformational states of SARS-CoV-2 spike protein

Acharya, P. D614G mutation alters SARS-CoV-2 spike conformational dynamics and protease cleavage susceptibility at the S1/S2 junction

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

Structures and distributions of SARS-CoV-2 spike proteins on intact virions

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite

Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike

A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2

Crispin, M. Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nat. Commun

Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition

Fine-tuning the Spike: Role of the nature and topology of the glycan shield structure and dynamics of SARS-CoV-2 S. bioRxiv 2021

Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor

The SARS-CoV-2 spike protein: balancing stability and infectivity

Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles

Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein

Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane

Elucidation of interactions regulating conformational stability and dynamics of SARS-CoV-2 Sprotein

Conformational transition of SARS-CoV-2 spike glycoprotein between its closed and open states

Differential Dynamic Behavior of Prefusion Spike Proteins of SARS Coronaviruses 1 and 2

A glycan gate controls opening of the SARS-CoV-2 spike protein

SARS-CoV-2 simulations go exascale to predict dramatic spike opening and cryptic pockets across the proteome

Free Energy Landscapes from SARS-CoV-2 Spike Glycoprotein Simulations Suggest that RBD Opening Can Be Modulated via Interactions in an Allosteric Pocket

3D implementation of the symbol nomenclature for graphical representation of glycans

Symbol Nomenclature for Graphical Representations of Glycans

A recipe for the computation of the free energy barrier and the lowest free energy path of concerted reactions

Conformations and free energy landscapes of polyproline peptides

Über Brownsche Molekularbewegung unter Einwirkung äußerer Kräfte und deren Zusammenhang mit der verallgemeinerten Diffusionsgleichung

Effective Riemannian Diffusion Model for Conformational Dynamics of Biomolecular Systems

Molecular dynamics simulation of the gramicidin channel in a phospholipid bilayer

Generalized Langevin Methods for Calculating Transmembrane Diffusivity

Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding

Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen

Virus vaccines: proteins prefer prolines

Receptor binding may directly activate the fusion machinery in coronavirus spike glycoproteins

Tackling COVID-19 with neutralizing monoclonal antibodies

Molecular Aspects Concerning the Use of the SARS-CoV-2

Receptor Binding Domain as a Target for Preventive Vaccines

Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes

CoV-AbDab: the coronavirus antibody database

Computational epitope map of SARS-CoV-2 spike protein

Structurally Resolved SARS-CoV-2 Antibody Shows High Efficacy in Severely Infected Hamsters and Provides a Potent Cocktail Pairing Strategy

A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV

Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody

SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface

Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms

ACE2 glycans preferentially interact with SARS-CoV-2 over SARS-CoV

Electrostatic Interactions Explain the Higher Binding Affinity of the CR3022 Antibody for SARS-CoV-2 than the 4A8 Antibody

Glycans on the SARS-CoV-2 Spike Control the Receptor Binding Domain Conformation

SWISS-MODEL: homology modelling of protein structures and complexes

Scalable molecular dynamics with NAMD

Scalable molecular dynamics on CPU and GPU architectures with NAMD

CHARMM36m: an improved force field for folded and intrinsically disordered proteins

CHARMM Additive All-Atom Force Field for Glycosidic Linkages between Hexopyranoses

Comparison of simple potential functions for simulating liquid water

Constant pressure molecular dynamics simulation: the Langevin piston method

Particle mesh Ewald: An N · log(N ) method for Ewald sums in large systems